OAM
ARNA

Oberweis Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Oberweis Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9,100
Closed -$408K – 216
2019
Q1 		$408K Hold
9,100
– – 0.08% 154
2018
Q4 		$354K Hold
9,100
– – 0.08% 162
2018
Q3 		$419K Buy
9,100
+2,500
+38% +$101K 0.08% 166
2018
Q2 		$288K Buy
6,600
+1,000
+18% +$43K 0.07% 199
2018
Q1 		$221K Sell
5,600
-1,700
-23% -$66.1K 0.06% 215
2017
Q4 		$248K Buy
+7,300
New +$208K 0.06% 218

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Oberweis Asset Management's ARNA Position: Q2 2019 in Review

Oberweis Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2019, closing a stake of 9,100 shares — an estimated $408K sold.

Oberweis Asset Management first reported a position in ARNA in Q4 2017 and held it in 6 quarters. The position peaked at $419K in Q3 2018. 215 funds tracked by Wall St. Rank hold ARNA as of Q2 2019.

  • Oberweis Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q2 2019 after selling out during the quarter.
  • Oberweis Asset Management sold 9,100 Arena Pharmaceuticals Inc shares in Q2 2019, an estimated $408K.
  • Oberweis Asset Management first reported a position in Arena Pharmaceuticals Inc in Q4 2017 and held it in 6 quarters.
  • Oberweis Asset Management's Arena Pharmaceuticals Inc position peaked at $419K in Q3 2018.
  • 215 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2019.

Based on Oberweis Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.